Christel Menet
Chief Scientific Officer Confo Therapeutics
Christel joined Confo Therapeutics as Chief Scientific Officer in 2016. Prior to that, Christel was Director of Medicinal Chemistry at Galapagos (2014–2016). Earlier in her career, Christel held medicinal chemistry roles at Evotec, Faust Pharmaceuticals (now Domain Therapeutics), and contributed to multiple drug discovery programs, advancing several compounds into preclinical and clinical development. Christel is an inventor on over 25 patent applications and hold a PhD in Organic Chemistry from the University of Manchester under Prof. Jonathan Clayden.
Seminars
Thursday 30th April 2026
Advancing Antibody Discovery for GPCR Targets Through In Vivo Validation of an Agonistic Antibody
11:00 am
- Describing the discovery strategy used to generate an agonistic antibody, including target selection and screening approaches
- Demonstrating in vivo validation of the agonistic antibody and the pharmacological activity observed across relevant models
- Detailing key translational learnings from the program and how these insights inform broader GPCR-directed antibody discovery efforts
